Literature DB >> 30393619

Identifying therapeutic vulnerabilities in lung cancer: application of a chemistry-first approach.

Sharon R Pine1,2,3, Bríd M Ryan4.   

Abstract

Entities:  

Year:  2018        PMID： 30393619      PMCID： PMC6193905          DOI： 10.21037/tlcr.2018.09.10

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN： 2218-6751


× No keyword cloud information.
  19 in total

1.  NCI-60 Cell Line Screening: A Radical Departure in its Time.

Authors:  Bruce A Chabner
Journal:  J Natl Cancer Inst       Date:  2016-01-11       Impact factor: 13.506

Review 2.  Proteasome inhibition in cancer: development of PS-341.

Authors:  J Adams
Journal:  Semin Oncol       Date:  2001-12       Impact factor: 4.929

3.  Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer.

Authors:  Hiu Wing Cheung; Glenn S Cowley; Barbara A Weir; Jesse S Boehm; Scott Rusin; Justine A Scott; Alexandra East; Levi D Ali; Patrick H Lizotte; Terence C Wong; Guozhi Jiang; Jessica Hsiao; Craig H Mermel; Gad Getz; Jordi Barretina; Shuba Gopal; Pablo Tamayo; Joshua Gould; Aviad Tsherniak; Nicolas Stransky; Biao Luo; Yin Ren; Ronny Drapkin; Sangeeta N Bhatia; Jill P Mesirov; Levi A Garraway; Matthew Meyerson; Eric S Lander; David E Root; William C Hahn
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-11       Impact factor: 11.205

4.  Survival improvement in patients with non-small cell lung cancer between 1983 and 2012: Analysis of the Surveillance, Epidemiology, and End Results database.

Authors:  Shuncong Wang; Tiantian Sun; Huanhuan Sun; Xiaobo Li; Jie Li; Xiaobin Zheng; Saradhi Mallampati; Hongliu Sun; Xiuling Zhou; Cuiling Zhou; Hongyu Zhang; Zhibin Cheng; Haiqing Ma
Journal:  Tumour Biol       Date:  2017-05

Review 5.  The National Cancer Institute: cancer drug discovery and development program.

Authors:  M R Grever; S A Schepartz; B A Chabner
Journal:  Semin Oncol       Date:  1992-12       Impact factor: 4.929

6.  Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting.

Authors:  Andrew J Aguirre; Robin M Meyers; Barbara A Weir; Francisca Vazquez; Cheng-Zhong Zhang; Uri Ben-David; April Cook; Gavin Ha; William F Harrington; Mihir B Doshi; Maria Kost-Alimova; Stanley Gill; Han Xu; Levi D Ali; Guozhi Jiang; Sasha Pantel; Yenarae Lee; Amy Goodale; Andrew D Cherniack; Coyin Oh; Gregory Kryukov; Glenn S Cowley; Levi A Garraway; Kimberly Stegmaier; Charles W Roberts; Todd R Golub; Matthew Meyerson; David E Root; Aviad Tsherniak; William C Hahn
Journal:  Cancer Discov       Date:  2016-06-03       Impact factor: 39.397

7.  TTC21B contributes both causal and modifying alleles across the ciliopathy spectrum.

Authors:  Erica E Davis; Qi Zhang; Qin Liu; Bill H Diplas; Lisa M Davey; Jane Hartley; Corinne Stoetzel; Katarzyna Szymanska; Gokul Ramaswami; Clare V Logan; Donna M Muzny; Alice C Young; David A Wheeler; Pedro Cruz; Margaret Morgan; Lora R Lewis; Praveen Cherukuri; Baishali Maskeri; Nancy F Hansen; James C Mullikin; Robert W Blakesley; Gerard G Bouffard; Gabor Gyapay; Susanne Rieger; Burkhard Tönshoff; Ilse Kern; Neveen A Soliman; Thomas J Neuhaus; Kathryn J Swoboda; Hulya Kayserili; Tomas E Gallagher; Richard A Lewis; Carsten Bergmann; Edgar A Otto; Sophie Saunier; Peter J Scambler; Philip L Beales; Joseph G Gleeson; Eamonn R Maher; Tania Attié-Bitach; Hélène Dollfus; Colin A Johnson; Eric D Green; Richard A Gibbs; Friedhelm Hildebrandt; Eric A Pierce; Nicholas Katsanis
Journal:  Nat Genet       Date:  2011-01-23       Impact factor: 38.330

8.  Systematic identification of genomic markers of drug sensitivity in cancer cells.

Authors:  Mathew J Garnett; Elena J Edelman; Sonja J Heidorn; Chris D Greenman; Anahita Dastur; King Wai Lau; Patricia Greninger; I Richard Thompson; Xi Luo; Jorge Soares; Qingsong Liu; Francesco Iorio; Didier Surdez; Li Chen; Randy J Milano; Graham R Bignell; Ah T Tam; Helen Davies; Jesse A Stevenson; Syd Barthorpe; Stephen R Lutz; Fiona Kogera; Karl Lawrence; Anne McLaren-Douglas; Xeni Mitropoulos; Tatiana Mironenko; Helen Thi; Laura Richardson; Wenjun Zhou; Frances Jewitt; Tinghu Zhang; Patrick O'Brien; Jessica L Boisvert; Stacey Price; Wooyoung Hur; Wanjuan Yang; Xianming Deng; Adam Butler; Hwan Geun Choi; Jae Won Chang; Jose Baselga; Ivan Stamenkovic; Jeffrey A Engelman; Sreenath V Sharma; Olivier Delattre; Julio Saez-Rodriguez; Nathanael S Gray; Jeffrey Settleman; P Andrew Futreal; Daniel A Haber; Michael R Stratton; Sridhar Ramaswamy; Ultan McDermott; Cyril H Benes
Journal:  Nature       Date:  2012-03-28       Impact factor: 49.962

9.  Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies.

Authors:  Glenn S Cowley; Barbara A Weir; Francisca Vazquez; Pablo Tamayo; Justine A Scott; Scott Rusin; Alexandra East-Seletsky; Levi D Ali; William Fj Gerath; Sarah E Pantel; Patrick H Lizotte; Guozhi Jiang; Jessica Hsiao; Aviad Tsherniak; Elizabeth Dwinell; Simon Aoyama; Michael Okamoto; William Harrington; Ellen Gelfand; Thomas M Green; Mark J Tomko; Shuba Gopal; Terence C Wong; Terrence C Wong; Hubo Li; Sara Howell; Nicolas Stransky; Ted Liefeld; Dongkeun Jang; Jonathan Bistline; Barbara Hill Meyers; Scott A Armstrong; Ken C Anderson; Kimberly Stegmaier; Michael Reich; David Pellman; Jesse S Boehm; Jill P Mesirov; Todd R Golub; David E Root; William C Hahn
Journal:  Sci Data       Date:  2014-09-30       Impact factor: 6.444

10.  A combinatorial strategy for treating KRAS-mutant lung cancer.

Authors:  Eusebio Manchado; Susann Weissmueller; John P Morris; Chi-Chao Chen; Ramona Wullenkord; Amaia Lujambio; Elisa de Stanchina; John T Poirier; Justin F Gainor; Ryan B Corcoran; Jeffrey A Engelman; Charles M Rudin; Neal Rosen; Scott W Lowe
Journal:  Nature       Date:  2016-06-22       Impact factor: 49.962
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.